RBC keeps EUR 25.00 target for Philips stock

Published on 10/16/2026 at 15:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RBC keeps its EUR 25.00 target from October 12, 2026. Philips stock costs EUR 22.95 on October 16, 2026, up 0.88 percent versus the Xetra close.

Analyst target and results date

RBC Capital maintained a Hold rating and a EUR 25.00 target on October 12, 2026.
Philips is expected to publish its next results on November 3, 2026.
Philips stock costs EUR 22.95 at Lang & Schwarz on October 16, 2026 at 3:07 p.m. CEST, 0.88 percent above the Xetra close of October 15, 2026.
The stock trades at a P/E ratio of 19.74 and has a market capitalization of EUR 22.4 billion.

Geometrisches Bauhaus-Poster mit Formen und Schriftzug TECH in Primärfarben — Koninklijke Philips N.V. (NL0000009538) inspiriert geometrisches Bauhaus-Poster mit Kreisen, Dreiecken und Sektor-Schriftzug TECH in Primärfarben, Illustration mit AI erstellt.

RBC Capital maintained a Hold rating on Philips and set a EUR 25.00 price target on October 12, 2026, according to Markets Insider. The target is 8.93 percent above Philips stock at EUR 22.95, using the Lang & Schwarz price on October 16, 2026 at 3:07 p.m. CEST. The stock stood 0.88 percent above the Xetra close of October 15, 2026.

Results date sets the next marker

Philips is scheduled to publish its next results on November 3, 2026, according to Simply Wall St. The date gives investors the next formal checkpoint for demand, margins and the company outlook. Philips last reported second-quarter 2026 revenue of EUR 4.36 billion, flat from the second quarter of 2025, while net income rose 59 percent to EUR 384.0 million.

Stock remains below its yearly high

The finance picture places Philips between a 52-week low of EUR 20.92 and a high of EUR 27.57 as of October 16, 2026. At EUR 22.95, the stock was 16.76 percent below the high and 9.71 percent above the low. Its market capitalization was EUR 22.4 billion, while the price-to-earnings ratio stood at 19.74.

That range matters because the current price is closer to the yearly low than the high. The second-quarter comparison also shows why the November report will matter: revenue was stable, but net income increased from EUR 241.5 million in the second quarter of 2025 to EUR 384.0 million in the second quarter of 2026.

Comparison with peers

Philips: plus 0.88 percent, P/E 19.74, market capitalization EUR 22.4 billion.

Siemens Healthineers (Xetra, EUR): plus 1.64 percent, P/E 20.97, market capitalization EUR 46.5 billion.

GE HealthCare (Nasdaq, USD): plus 2.75 percent, P/E 20.39, market capitalization USD 31.8 billion.

Valuation and trading position

RBC Capital's EUR 25.00 target leaves 8.93 percent to the target from the Lang & Schwarz price. The analyst view therefore sits above the current quote, while the stock's 19.74 P/E ratio is below Siemens Healthineers at 20.97 and GE HealthCare at 20.39.

Philips remains a health technology company listed on Euronext Amsterdam under PHIA. The next scheduled results date is November 3, 2026, and the second-quarter figures provide the latest periodized operating reference for that event.

Trading stays above the Xetra close

Philips stock was trading at EUR 22.95 at Lang & Schwarz on October 16, 2026 at 3:07 p.m. CEST, up 0.88 percent versus the Xetra close of October 15, 2026 at EUR 22.75. The quote remains within the EUR 20.92 to EUR 27.57 52-week range.

The further course of trading is shown by the continuously updated real-time quote of Philips stock.